Search
Search Results
##search.searchResults.foundPlural##
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3655PDF: 1519HTML: 8006Randi Fig: 160 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1239PDF: 832HTML: 1023Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 155 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2732PDF: 1083HTML: 11206 -
SOLITARY PLASMACYTOMA
3751PDF: 2127HTML: 1199fIGURES 1,2: 191 -
Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome Alpha Thalassemia and RNF 213 Gene Mutation in Moyamoya
887PDF: 665HTML: 214 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2313PDF: 888HTML: 486 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1869PDF: 706HTML: 678 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2738PDF: 980HTML: 5497 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
988PDF: 931HTML: 302 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
704PDF: 453HTML: 6247 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4130PDF: 1486HTML: 426 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1183PDF: 699HTML: 291 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1202PDF: 453HTML: 18543Figure 1: 154Figure 2: 138Figure 3: 154Figure 4: 187Figure 5: 158 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4242PDF: 1449HTML: 1531Untitled: 210 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2372HTML: 252PDF: 823 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4337PDF: 1872HTML: 17710 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1729PDF: 781HTML: 10206Figures 1,2,3: 152 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1872PDF: 770HTML: 204 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
670PDF: 788PDF Supp. Files: 69HTML: 170 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1337PDF: 797HTML: 3103
1 - 40 of 40 items







